Capital One National Association’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
BIT
BFA
Capital One National Association's ALNY Position: Q2 2016 in Review
Capital One National Association sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2016, closing a stake of 19,764 shares — an estimated $1.24M sold.
Capital One National Association first reported a position in ALNY in Q4 2015 and held it in 2 quarters. The position peaked at $1.88M in Q4 2015. 248 funds tracked by Wall St. Rank hold ALNY as of Q2 2016.
- Capital One National Association reported no remaining Alnylam Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
- Capital One National Association sold 19,764 Alnylam Pharmaceuticals shares in Q2 2016, an estimated $1.24M.
- Capital One National Association first reported a position in Alnylam Pharmaceuticals in Q4 2015 and held it in 2 quarters.
- Capital One National Association's Alnylam Pharmaceuticals position peaked at $1.88M in Q4 2015.
- 248 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2016.
Based on Capital One National Association's 13F filing for Q2 2016, filed 19 Jul 2016.